Dear Editor, I read with great interest the article in your journal by Besouw et al. titled BClinical and molecular aspects of distal renal tubular acidosis in children^ [1] . The authors reported that 16 of 24 patients with distal renal tubular acidosis (dRTA) showed transient and partial renal Fanconi syndrome that resembled Dent disease or Lowe syndrome. This finding suggested that renal Fanconi syndrome in dRTA may be due to impairment of similar pathways in both diseases. Molecular analysis of vacuolar H + -ATPase (V-ATP) in their dRTA patients with renal Fanconi syndrome showed nine had the ATP6V0A4 mutation, three the ATPV1B1 mutation, and four had no apparent gene mutation.
Renal proximal tubular dysfunction in untreated patients with dRTA has also been reported previously [1, 2] . Although the precise pathogenic mechanism underlying development of this condition remains unclear, it has been suggested that hypokalemic nephropathy and defective V-ATPase resulting in impaired endosomal acidification may be involved [1, 2] . However, because the B1 subunit of VATPase is not expressed in renal proximal tubular cells, defective V-ATPase is unlikely to cause renal proximal tubular dysfunction in dRTA patients with the ATPV1B1 mutation [2] .
Expression of CLC-5 (2Cl − /H + exchanger) in apical endosomes of renal proximal tubules containing V-ATPase acts functionally in the normal endosomal pathway coupling with V-ATPase. In contrast, genetic mutations of CLC-5 cause Dent disease [3] . Recent studies demonstrated that low extracellular pH or acidosis inhibits CLC-5 function that occurs as a consequence of a reduction in the driving force for exchange caused by the pH gradient [4] . Inhibition of CLC-5 function due to systemic acidosis may lead to renal proximal tubular dysfunction in pretreated patients with dRTA.
Compliance with ethical standards
Conflict of interest The author declares no conflict of interest
